![Karen Basbaum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Basbaum
Corporate Officer/Principal bei
MBX BIOSCIENCES, INC.
Profil
Karen Basbaum is Chief Business Officer at MBX Biosciences, Inc. since 2026.
Former roles include Director-Business Development at Amylin Pharmaceuticals, Inc., Senior Vice President-Business Development at DNAtrix, Inc., Vice President-Business Development at Elcelyx Therapeutics, Inc. from 2016 to 2017, Vice President-Business Development at Dauntless Pharmaceuticals, Inc. from 2017 to 2019, and Senior Vice President-Business Development at Poseida Therapeutics, Inc. Education includes graduate studies at Rensselaer Polytechnic Institute, undergraduate studies at the University of North Dakota, and an MBA from Paul Merage School of Business.
Aktive Positionen von Karen Basbaum
| Unternehmen | Position | Beginn |
|---|---|---|
| MBX BIOSCIENCES, INC. | Corporate Officer/Principal | 10.03.2026 |
Ehemalige bekannte Positionen von Karen Basbaum
| Unternehmen | Position | Ende |
|---|---|---|
Dauntless Pharmaceuticals, Inc.
 Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops specialty drugs | Corporate Officer/Principal | 01.02.2019 |
Elcelyx Therapeutics, Inc.
 Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics based on gut sensory modulation | Corporate Officer/Principal | 01.01.2017 |
DNAtrix, Inc.
 DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Corporate Officer/Principal | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | - |
| POSEIDA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Karen Basbaum
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
29
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
DNAtrix, Inc.
DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology Operates as a biotech company which focuses on the development of oncolytic viruses for cancer | Electronic Technology |
Elcelyx Therapeutics, Inc.
Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics based on gut sensory modulation | Health Technology |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of North Dakota
 University of North Dakota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paul Merage School of Business
 Paul Merage School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dauntless Pharmaceuticals, Inc.
Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops specialty drugs | Retail Trade |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
